Press release content from Globe Newswire. The AP news staff was not involved in its creation.
TILT Holdings Enters Third Market through the Completion of Its Acquisition of Ohio Processing .
TILT Holdings Inc.March 16, 2021 GMT
PHOENIX, March 16, 2021 (GLOBE NEWSWIRE) TILT Holdings Inc. (“TILT or the “Company”) ( CSE: TILT ) ( OTCQX: TLLTF ), a provider of business solutions to the global cannabis industry that includes inhalation technologies, cultivation, manufacturing, processing, brand development, distribution and retail, announced that it has completed its acquisition of Standard Farms Ohio LLC (“SFO”), previously announced on April 16, 2019.
ADVERTISEMENT
SFO’s purpose-built 9,600 sq. ft. processing and CO2 extraction facility (the “Facility”) is conveniently located just outside of Cleveland, providing ready access to the state’s 52 operating dispensaries. The Facility currently produces high-quality medical cannabis products including tinctures, vap
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Meltwater announces agreement to acquire leading social media intelligence company Linkfluence .
MeltwaterMarch 16, 2021 GMT
OSLO, Norway, March 16, 2021 (GLOBE NEWSWIRE) Meltwater B.V., a leading global provider of media intelligence and social analytics, has entered into an agreement under which it is committed to acquire Linkfluence, a French SaaS company using artificial intelligence to algorithmically mine social media for consumer insights.
The Linkfluence acquisition would be Meltwater’s ninth since 2016, and the first since the company was listed on Euronext Growth Oslo in December 2020. The acquisition is part of Meltwater’s growth strategy, which involves investments and acquisitions in the social media segment.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of Mergers
Rigrodsky Law, P.AMarch 16, 2021 GMT
WILMINGTON, Del., March 16, 2021 (GLOBE NEWSWIRE) Rigrodsky Law, P.A. announces that it is investigating:
Fortress Value Acquisition Corp. II (NYSE: FAII ) regarding possible breaches of fiduciary duties and other violations of law related to Fortress Value’s agreement to merge with Wilco Holdco, Inc. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-fortress-value-acquisition-corp-ii.
ADVERTISEMENT
Leisure Acquisition Corp. (NASDAQ GS: LACQ ) regarding possible breaches of fiduciary duties and other violations of law related to Leisure’s agreement to merge with Ensysce Biosciences, Inc. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-leisure-acquisition-corp.
Gilead, Merck to team up on potential HIV combo treatment The two major pharmaceutical firms have agreed to jointly develop and commercialize treatment combinations of lenacapavir and islatravir in HIV patients.
Gilead Sciences and Merck have entered into an agreement to co-develop and co-commercialize long-acting treatments in HIV. The intended solutions will combine Gilead’s investigational capsid inhibitor, lenacapavir, and Merck’s investigational nucleoside reverse transcriptase translocation inhibitor, islatravir, into a two-drug regimen with the potential to provide new, meaningful treatment options for people with HIV.
Islatravir and lenacapavir are potentially first-in-class medicines in late-stage clinical trials, with significant clinical data generated for both to date. Each of the medicines reportedly has a long half-life and has demonstrated activity at low dosages in clinical studies, which support development as an investigational com